Literature DB >> 11877669

VEGF upregulates Bcl-2 expression and is associated with decreased apoptosis in neuroblastoma cells.

Elizabeth A Beierle1, Louise F Strande, Mike K Chen.   

Abstract

BACKGROUND/
PURPOSE: Both the expression of Bcl-2 and the amount of vascular endothelial growth factor (VEGF) are increased in neuroblastoma cells cocultured with hepatocytes. The authors hypothesize that VEGF upregulates Bcl-2 expression by the neuroblastoma cells and protects them from apoptotic stimuli.
METHODS: To determine whether VEGF will induce Bcl-2 expression in neuroblastoma cells, the cells are plated with standard media (control) or media supplemented with VEGF. After 24 hours, Bcl-2 expression is measured. To determine whether VEGF protects neuroblastoma cells from apoptosis, the cells are subjected to tumor necrosis factor alpha (TNF-alpha) or serum starvation to induce apoptosis either with or without VEGF added to the culture media. The cells are collected and apoptosis measured using the deoxynucleotidyltransferase-mediated dUTP neck end labeling (TUNEL) method.
RESULTS: VEGF increases Bcl-2 expression by 33% over cells cultured in standard media. Serum starving the tumor cells or adding TNF-alpha significantly increases the percentage of apoptotic cells. The addition of VEGF significantly protects the neuroblastoma cells from the apoptotic effects of both serum starvation and TNF-alpha.
CONCLUSIONS: VEGF increases the expression of Bcl-2 and also abrogates TNF-alpha and serum starvation-induced apoptosis in neuroblastoma cells in vitro. VEGF may promote neuroblastoma survival not only through angiogenesis, but also by altering apoptosis and its regulating proteins. Copyright 2002 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877669     DOI: 10.1053/jpsu.2002.30868

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  17 in total

Review 1.  Cell survival signaling in neuroblastoma.

Authors:  Michael L Megison; Lauren A Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

2.  Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Jing Lei; Qian Han; Shaocheng Zhu; Dapeng Shi; Shewei Dou; Zihua Su; Xiao Xu
Journal:  Oncol Lett       Date:  2015-10-05       Impact factor: 2.967

3.  Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury.

Authors:  Chuan Hua He; Aaron B Waxman; Chun Geun Lee; Holger Link; Morgan E Rabach; Bing Ma; Qingsheng Chen; Zhou Zhu; Mei Zhong; Keiko Nakayama; Keiichi I Nakayama; Robert Homer; Jack A Elias
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

4.  Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.

Authors:  Shakeel Modak; Brian H Kushner; Ellen Basu; Stephen S Roberts; Nai-Kong V Cheung
Journal:  Pediatr Blood Cancer       Date:  2017-01-23       Impact factor: 3.167

5.  Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume.

Authors:  Fanxia Shen; Espen J Walker; Lidan Jiang; Vincent Degos; Jianping Li; Baoliang Sun; Fransisca Heriyanto; William L Young; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-20       Impact factor: 6.200

6.  Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.

Authors:  Maria Peiris-Pagès; Steven J Harper; David O Bates; Pramila Ramani
Journal:  J Pathol       Date:  2010-10       Impact factor: 7.996

7.  RNA interference-mediated gene silencing of vascular endothelial growth factor in colon cancer cells.

Authors:  Tie-Jun Li; Jian-Ning Song; Kai Kang; Shu-Sheng Tong; Zan-Lan Hu; Tong-Chuan He; Bing-Qiang Zhang; Cai-Quan Zhang
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

8.  Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.

Authors:  Surajit Karmakar; Kristin A Davis; Subhasree Roy Choudhury; Anurag Deeconda; Naren L Banik; Swapan K Ray
Journal:  Biochem Biophys Res Commun       Date:  2009-08-18       Impact factor: 3.575

9.  Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease.

Authors:  Thomas L Sims; Regan F Williams; Cathy Y Ng; Shannon F Rosati; Yunyu Spence; Andrew M Davidoff
Journal:  Surgery       Date:  2008-08       Impact factor: 3.982

10.  Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.

Authors:  Sudha Neelam; Morgan M Brooks; Patrick R Cammarata
Journal:  Mol Vis       Date:  2013-01-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.